Assertio Holdings (ASRT) Shares Outstanding (Diluted Average) (2019 - 2026)
Assertio Holdings' (ASRT) quarterly Shares Outstanding (Diluted Average) came in at $6.4 million in Q1 2026, up 0.88% year-on-year from $6.4 million in Q1 2025, and little changed quarter-over-quarter from $6.4 million in Q4 2025.
Assertio Holdings (ASRT) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends
Assertio Holdings has disclosed Shares Outstanding (Diluted Average) across 8 years of filings, most recently posting $6.4 million for Q1 2026.
- Shares Outstanding (Diluted Average) for Q1 2026 came in at $6.4 million, up 0.88% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.4 million (up 0.88% YoY), and the FY2025 annual result was $6.4 million, up 0.82% from the prior year.
- Shares Outstanding (Diluted Average) came in at $6.4 million for Q1 2026 at Assertio Holdings, roughly flat from $6.4 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $96.0 million in Q2 2025 to a low of $6.4 million in Q4 2024.
- The 5-year median for Shares Outstanding (Diluted Average) is $57.4 million (2022), against an average of $56.7 million.
- Across the five-year window, Shares Outstanding (Diluted Average) jumped 86.22% in 2024 and tumbled 93.28% in 2025, its largest moves.
- Assertio Holdings' Shares Outstanding (Diluted Average) stood at $54.7 million in 2022, then gained by 29.93% to $71.0 million in 2023, then sank by 91.06% to $6.4 million in 2024, then advanced by 0.82% to $6.4 million in 2025, then advanced by 0.48% to $6.4 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $6.4 million (Q1 2026), $6.4 million (Q4 2025), and $96.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Assertio Holdings | 150.78 Mn | 79.21 Mn | 7.22 Mn | 6.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.43 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 95.97 Mn |
| Jun 30, 2025 | 95.97 Mn |
| Mar 31, 2025 | 6.38 Mn |
| Dec 31, 2024 | 6.35 Mn |
| Sep 30, 2024 | 95.35 Mn |
| Jun 30, 2024 | 95.24 Mn |
| Mar 31, 2024 | 94.98 Mn |
| Dec 31, 2023 | 71.03 Mn |
| Sep 30, 2023 | 63.07 Mn |
| Jun 30, 2023 | 70.14 Mn |
| Mar 31, 2023 | 51.01 Mn |
| Dec 31, 2022 | 54.67 Mn |
| Sep 30, 2022 | 57.39 Mn |
| Jun 30, 2022 | 47.58 Mn |
| Mar 31, 2022 | 46.13 Mn |
| Dec 31, 2021 | 43.17 Mn |
| Sep 30, 2021 | 42.55 Mn |
| Jun 30, 2021 | 44.71 Mn |